Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator …
…, R Hoepner, VU Bacher, LY Mani, JM Iype… - The Lancet …, 2021 - thelancet.com
Background B-cell-depleting therapies increase the risk of morbidity and mortality due to
COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting …
COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting …
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
…, A Chan, R Hoepner, U Bacher, LY Mani, JM Iype… - RMD open, 2022 - rmdopen.bmj.com
Background The majority of patients with B-cell-depleting therapies show compromised
vaccination-induced immune responses. Herein, we report on the trajectories of anti-SARS-CoV-…
vaccination-induced immune responses. Herein, we report on the trajectories of anti-SARS-CoV-…
Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-cell depleting therapy
…, A Chan, R Hoepner, VU Bacher, LY Mani, JM Iype… - medRxiv, 2021 - medrxiv.org
Background B-cell depleting therapies increase COVID19 morbidity and mortality. For this
specific population, evidence-based vaccination strategies are lacking. Here, we investigated …
specific population, evidence-based vaccination strategies are lacking. Here, we investigated …
Longitudinal analysis of antibody trajectories and humoral responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 …
…, A Chan, R Hoepner, U Bacher, LY Mani, JM Iype… - MedRxiv, 2021 - medrxiv.org
Background Morbidity and mortality of COVID-19 is increased in patients with B-cell depleting
therapies, the majority of which also show compromised vaccination-induced immune …
therapies, the majority of which also show compromised vaccination-induced immune …
[PDF][PDF] Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
GA Scholz, M Fux, LA Christ, JM Iype… - Journal of …, 2022 - boris.unibe.ch
1. Objective Giant Cell Arteritis (GCA) is the most prevalent large vessel vasculitis in Western
countries. Its pathophysiological hallmark is an imbalance of regulatory T (Treg), T helper (…
countries. Its pathophysiological hallmark is an imbalance of regulatory T (Treg), T helper (…
[PDF][PDF] Analysis of histone deacetylase families of Arabidopsis thaliana and Oryza sativa
JM Iype, R Mishra, S Karthikeyan… - African Journal of …, 2013 - academicjournals.org
Histone deacetylases (HDACs) plays critical roles in the regulation of chromatin structure and
gene expression. HDACs are highly conserved in yeast, animals and plants, suggesting a …
gene expression. HDACs are highly conserved in yeast, animals and plants, suggesting a …
[HTML][HTML] search result for-language
AY Aldahesh - International Journal, 2013 - academicjournals.org
The phenomenon of idiomaticity constitutes a common factor in all living languages and its
appreciation is considered the cornerstone of learning and mastering any given language. …
appreciation is considered the cornerstone of learning and mastering any given language. …
[CITATION][C] Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-cell depleting therapy (preprint)
…, A Chan, R Hoepner, VU Bacher, LY Mani, JM Iype… - 2021
[CITATION][C] nd “Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-Cell depleting therapy.”
…, A Chan, R Hoepner, VU Bacher, LY Mani, JM Iype… - MedRxiv preprint doi: https://doi …